Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I think this is automatic info sent out by the Investors meet company platform... to do these types of calls / presentations presumably they will have to book a slot and pay for this service
I note there is inconsistencies within the RNS - the last two are very different in the "About Physiomics Jazz" at the bottom.
I also note that why has the latest RNS got a "Question Mark ? " after virtual Tumour and CRUK has been droppped?
if this is merely a mistake then the attention to detail !!!!
RNS 1st March 2024
About Physiomics
Physiomics plc (AIM: PYC) is an oncology consultancy using mathematical models to support the development of cancer treatment regimens and personalised medicine solutions. The Company's Virtual Tumour? technology uses computer modelling to predict the effects of cancer drugs and treatments to improve the success rate of drug discovery and development projects while reducing time and cost. The predictive capability of Physiomics' technologies have been confirmed by over 100 projects, involving over 50 targets and 75 drugs, and has worked with clients such as Merck KGaA, Astellas, Merck & Co and Bicycle Therapeutics.
RNS 19th February 2024
About Physiomics
Physiomics plc combines cutting edge PKPD and QSP modelling and data science techniques, along with deep biology expertise, to help biotech and pharma companies streamline their drug development journeys.
Our approach is to derive insight from all relevant data in order to de-risk decision making and optimise design research across discovery, pre-clinical and clinical studies.
Through use of bespoke models and our proprietary Virtual Tumour technology, the Physiomics team has informed the development of over 100 commercial projects, over 50 targets and 75 drugs. Clients include Merck KGaA, Astellas, Bicycle Therapeutics, Numab Therapeutics & CRUK.
Strange, not sure if PYC has did this in the past when Interims posted.
https://x.com/InvestorMeetCo/status/1763589672016449891?s=20
Thursday 7th March for half year ended Dec 2023
I posted this early January :
A PYC tweet issued last week included 'We can’t wait to share with you all the exciting developments we have planned for the year ahead'. Interestingly, Valirx issued a similarly worded tweet including 'we're looking forward to showing you what we have planned for an exciting year ahead'
Probably coincidence or perhaps they use the same script writer. Could it be there is some form of closer working relationship between the two planned ?
I note that there have been no exciting developments this calendar year on either PYC or VAL. Clarification will be needed on the tweet at Physiomics IMC presentation later this month if nothing substantial announced by then
Interims will be next week I think.
This week we had following low trades.
Mon 61
Tue 31
Wed 33
Thur 33
Fri. 33
Next week maybe RNS for Interims, will this have an effect on SP?
Will there be another RNS?
Going wild another 33 lol
Someone is building a sizable chunk here with all these trades.... :-)
Needs to be questioned….
BOD of directors all used to work for the same company.
Val Lab PYC has an agreement with
Scientific Advisory Board Together.
All seems like they getting tighter…. VAL has been decimated (so have we mind) but doesn't give a good vibe
KingH I totally agree with your sentiment
Was Global Senior Vice President and Head of Capital Solutions for Syneos Health
Syneos is where Dr Peter Sagenent and Dr Kumar used to work….
The relationship seems to be getting closer which I’m
Not sure is a good thing….
PYC needs to stay away from Val in my eyes……
2 little thingies ... 33
Jim also stated that there would be an RNS about meeting / exceeding or not exceeding expectations???
People are holding the stock they have whilst awaiting the next news which is a reasonable thing to do
Next trigger could be the half year results due next week. Following poor figures last year JM recently commented that PYC were 'on track' to turning things around. What that translates into remains to be seen
There is zero volume - no one is interested- my concern is even a few more contracts and the price won’t move.
I’m not sure the BOD have an understanding of The market and also creating value for all.
I mean when did they last buy shares / exercise on options….
Trouble is with the phrase "watch this space" there is no timeline associated with it. Significant news could land today or in years. The phrase may have been said in good faith, a snapshot at that particular time.
There may be X amount of deals about to be signed off, but we know delays happen, and deals dont get across the line from 1 reason or another.
Does not matter how much Laura puts the positive points across this board, until substantial news lands, we are not going anywhere? Even the TA's are avoiding this stock?
There will undoubtedly be people sitting on the sidelines waiting to jump in on decent news. It is not the way I invest, but it is clearly the way many people play AIM these days
Closing off contracts does clearly take time. The initial University of Sheffield contract was May 2023 with the comment that 'a longer-term collaboration is currently under discussion'. Even so, the second contract was only announced just over a week ago
There is literally zero interest- not even people picking stock up at these lows. Volume is pretty much zero which is awful tbh
Even with a few new contracts what’s it going to do move to 1.60 then float back down again. The past two minimal contracts set it south.
Nothing substantial as promised!? The share price seems to say no news . Back at our Low !
Very frustrating!
Since the 2nd Feb presentation there have been updates on 5th 6th and 19th Feb, would like to see bigger contracts now (albeit the range can be varied £50k to £250k+) and hopefully cumulative
Has anyone contacted Peter yet? I am happy to try if that email debull put here is the correct one ?
From the presentation
Options for Peter will be released via RNS
Jim entirely committed to PYC and to work with the team
Peter driving revenues and last few months seen "pipleine momentum"
27 29 significant progress in pipeline "very busy" over last month signals "very positive from new and existing clients" and "watch this space " in terms of updates on contracts
29 project optimus
Well there suppose to be a Investors meet company meeting next month as per previous announcement- obvs if there’s no further updates then the BOD will be shot to pieces after stating (contracts watch this space etc)
Let’s hope we get some contracts and it’s not just a load of BS like the BOD at VAL
And the 'watch this space' message ?
Gary has gone from 3.32% to 3.69%
Good to see Gary Marshall still sat there with 3.69% I think his name appeared after the raise early in 2023. Its also good to see Ben Rydens name appear again, as i also think that name was on the list a few years ago?
One could have thought that Gary could have gone in heavy at the raise, and sold their holding through 2023 for at least 50%, but they have stayed constant.